Xenon Pharmaceuticals, Inc. (XENE)

42.23 -0.85 (-1.97%) USD  |  NASDAQ  |  Feb 20, 16:00
42.46 +0.23 (+0.54%) Pre-Market: 08:01
More

Xenon Pharmaceuticals Ending Cash (Quarterly)

Ending Cash (Quarterly) Chart

View Ending Cash (Quarterly) for XENE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Ending Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Ending Cash (Quarterly) Range, Past 5 Years

View Ending Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Ending Cash (Quarterly) Benchmarks

View Ending Cash (Quarterly) Benchmarks
Start Trial
Oncolytics Biotech, Inc. Upgrade
Aurinia Pharmaceuticals, Inc. Upgrade
Edesa Biotech, Inc. Upgrade
Lexaria Bioscience Corp. Upgrade
ProMIS Neurosciences, Inc. Upgrade